Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
SRPT:NASDAQ
Sarepta Therapeutics Inc
US$21.49
+2.92%
(+0.61) 1D
US$21.12
-1.72% (-0.37)
Pre-market
Closed: 1 મે, 04:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRPT...
ખોલો
US$20.93
High
US$21.66
Low
US$20.92
Mkt. cap
૨.૨૭ અબજ
Volume
૪૫૨.૦૦
52-wk high
US$64.80
52-wk low
US$10.42
EPS
-US$7.13
Beta
૦.૨૬
Shares outstanding
૧૦.૫૦ કરોડ
No. of employees
૮૩૫
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
1 દિવસ પહેલાં
Do Sarepta Therapeutics’ (SRPT) Bullish Earnings Forecasts and Vanguard Stake Hint at a Shifting Risk Profile?
Newser
Newser
·
1 મહિના પહેલાં
SRPT Rallies on Dividend News
પ્રોફાઇલ
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc
CEOડગ્લસ એસ. ઇંગ્રમ
Employees835
Founded1980
Headquarters-
Sector-
Websitesarepta.com
Last report
25 ફેબ્રુ, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-૩.૫૮/ (-૦.૭૭ est.)USD
-365.29%miss
Revenue / Estimate
૪૪.૨૯ કરોડ/ (૩૯.૧૦ કરોડ est.)USD
+13.30%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
માર્ચ 2025
જૂન 2025
સપ્ટે 2025
ડિસે 2025
Revenue
74.49 કરોડ
61.11 કરોડ
39.94 કરોડ
44.29 કરોડ
Cost of goods sold
91.10 કરોડ
35.70 કરોડ
36.97 કરોડ
72.40 કરોડ
Cost of revenue
91.10 કરોડ
35.70 કરોડ
36.97 કરોડ
72.40 કરોડ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.36 કરોડ
13.79 કરોડ
9.19 કરોડ
12.83 કરોડ
Operating expense
13.42 કરોડ
13.86 કરોડ
9.26 કરોડ
12.90 કરોડ
Total operating expenses
1.05 અબજ
49.55 કરોડ
46.22 કરોડ
85.30 કરોડ
Operating income
-30.04 કરોડ
11.56 કરોડ
-6.29 કરોડ
-41.01 કરોડ
Other non operating income
-3.29 લાખ
-5.73 લાખ
-7.02 લાખ
-3.38 લાખ
EBT including unusual items
-38.35 કરોડ
15.36 કરોડ
-19.40 કરોડ
-27.83 કરોડ
EBT excluding unusual items
-29.50 કરોડ
11.50 કરોડ
-6.39 કરોડ
-42.32 કરોડ
Income tax expense
6.40 કરોડ
-4.33 કરોડ
-1.41 કરોડ
45.51 લાખ
Effective tax rate
-16.68%
-28.15%
7.27%
-1.64%
Other operating expenses
-
-
-
-
Net income
-44.75 કરોડ
19.69 કરોડ
-17.99 કરોડ
-28.28 કરોડ
Net profit margin
-60.08%
32.22%
-45.06%
-63.86%
Earnings per share
-3.42
2.02
-0.13
-3.58
Interest and investment income
1.02 કરોડ
52.54 લાખ
72.49 લાખ
80.70 લાખ
Interest expense
-45.03 લાખ
-52.28 લાખ
-75.65 લાખ
-2.08 કરોડ
Net interest expenses
56.87 લાખ
26.00 હજાર
-3.16 લાખ
-1.28 કરોડ
Depreciation and amortization charges
-
-
-
-
EBITDA
-29.04 કરોડ
12.64 કરોડ
-4.44 કરોડ
-40.48 કરોડ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer